Celligenics is a biotechnology company specialised in the development of future-relevant solutions through stem cell technology in a new era of regenerative medicine. Celligenics aims to be a global leader in the innovative isolation and application of human stem cells and its derivatives, and to empower humanity with unprecedented regenerative healthcare solutions that will enhance the quality of human life. Celligenics possesses strong credentials in the dual-facet of enterprise development and scientific research. The collective team has core expertise in enterprise strategy, investment finance, research & development, as well as experience in the field of working with molecular and cell biology.